drugset / Trial / NCT01795144

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

NCT01795144

Phase 1 Completed 10 enrolled University of Chicago
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to explore the mechanisms of metabolic control in monogenic diabetes patients treated with sulfonylurea medications.

Timeline

Start
2014-01
Primary completion
2017-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Avexitide Peptide
Subject GLP-1 Peptide

Indications